<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210925052567N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-29</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Educational Intervention Based on Self-Care Strategies on Self-Compassion and COVID-19 Prevention</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Educational Intervention Based on Self-Care Strategies on Self-Compassion and COVID-19 Prevention in Nurses of Corona Wards in Hospitals Related to Shahid Beheshti University of Medical Science in 1400</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/58918</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: Regarding the assignment of study groups, since this study is a fixed size design, 40 people will be in the intervention group and 40 people in the control group, Randomization description: Firstly, 8 hospitals related to Shahid Beheshti University of Medical Science  will be selected  through simple random sampling using  graph pad random number calculator site and then the hospitals will be divided into two groups of intervention and control through block balanced randomization.To form the quadruple blocks, we write all the positions of the letters T and C together, which include the following: TTCC, TCTC, TCCT, CTTC, CTCT, CCTT
T is the intervention group and C is the control group. Then we number these six states from one to six. To determine the number of required blocks, we  divide the number of hospitals to the type of block (4), which in this study will be 2 blocks. From the table of random numbers, we select 6 random numbers from one to six and accordingly we choose from the blocks and based on this, the hospitals are divided into two groups of control and intervention.
Finally from each hospital, 10 nurses working in the corona ward will be selected through simple random sampling using  graph pad random number calculator site.</study_design>
      <phase>N/A</phase>
      <hc_freetext>COVID-19 Prevention.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:If the sample is placed in the intervention group, self-care educational content will be provided for them via virtual messengers. Content will be sent to the intervention group 3 times (once a week). Questioning and answering will also be through the same virtual messaging system. Training is individual. In this educational intervention, different educational methods oral contact, written and combined methods such as speech (sending voice) with questioning and answering, practical demonstrations  and written media presentation such as pamphlets or educational videos and slides will be used. The content of the training will be based on self-care strategies in 6 areas: physical, occupational, social, emotional, psychological and spiritual, which are  according to the latest standard guidelines of the prevalence of Covid-19 epidemics. Intervention 2: Control group: At the beginning of the study, questionnaires will be also given to the control group, but training will not be done in this group. In order to comply with ethical standards, educational content will be provided to the control group at the end of the study.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All the participant data sets are to be shared after individuals are unidentified

When:
Start access after printing

To whom:
Researchers working in academic and scientific institutions

Conditions:
In order to use the documents of this study, mentioning the name of the researchers of this study is essential.

Where to obtain:
Applicants can receive the documents from the main researcher or the university and contact the main researcher via e-mail address (www.elahemehrabi1995@yahoo.com or www.meimanathosseini@yahoo.com) to receive the documents.

How to obtain:
Applicants can receive the files after submitting their request to receive the files via email to the main researcher (www.elahemehrabi1995@yahoo.com or www.meimanathosseini@yahoo.com).

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Meimanat Hosseini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vali Asr St., Niayesh Intersection, in front of Shahid Rajaei Heart Hospital,Tehran School of Nursing and Midwifery</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>Meimanathosseini@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Meimanat Hosseini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vali Asr St., Niayesh Intersection, in front of Shahid Rajaei Heart Hospital, Tehran., School of Nursing and Midwifery</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>Meimanathosseini@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Have healthy physical appearance and the absence of underlying disease
Access to the Internet and social networks
Not being infected with Covid-19 during the last 6 months
Not participating simultaneously in similar classes or researches to this research
Consent to participate in research
Bachelor certification at least</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Being infected by COVID-19 during last 6 months
Inaccessibility to the Internet and social networks
Participating simultaneously in similar classes or researches  to this research</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>U07. 1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>COVID-19, virus identified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:If the sample is placed in the intervention group, self-care educational content will be provided for them via virtual messengers. Content will be sent to the intervention group 3 times (once a week). Questioning and answering will also be through the same virtual messaging system. Training is individual. In this educational intervention, different educational methods oral contact, written and combined methods such as speech (sending voice) with questioning and answering, practical demonstrations  and written media presentation such as pamphlets or educational videos and slides will be used. The content of the training will be based on self-care strategies in 6 areas: physical, occupational, social, emotional, psychological and spiritual, which are  according to the latest standard guidelines of the prevalence of Covid-19 epidemics.</i_keyword>
      <i_keyword>Control group: At the beginning of the study, questionnaires will be also given to the control group, but training will not be done in this group. In order to comply with ethical standards, educational content will be provided to the control group at the end of the study</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Promoting self-compassion. Timepoint: At the beginning of the study, immediately after the study and one month after the study. Method of measurement: 1-Demographic Information Questionnaire 2-Neff's Self-Compassion Scale (Long Form).</prim_outcome>
      <prim_outcome>Corona prevention. Timepoint: At the beginning of the study, immediately after the study and one month after the study. Method of measurement: Coronavirus KAP Questionnaire (the knowledge, attitude and practice about coronavirus).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-20</approval_date>
        <contact_name>Ethics Committee of Schools of Pharmacy, Nursing and Midwifery, Shahid Beheshti University of Medica</contact_name>
        <contact_address>No. 2, Moghadas Ave., Sazman Ab Blvd., Halimiye Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
